You Searched For "merck molnupiravir pill covid 19" and got 19 results
Sort By:
2 mins read
Merck jumps 10% as the drugmaker says its antiviral pill cuts the risk of hospitalizations and deaths in COVID patients
Merck already has a deal to supply 1.7 million courses of antiviral pill molnupiravir to the US gov…
Carla Mozée
1 min read
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla Mozée
2 mins read
Sun Pharma gets emergency use authorization to manufacture Merck's anti-Covid pill Molnupiravir
Amid the ongoing resurgence of new Covid-19 cases in India, an expert panel of the Central Dru…
4 mins read
The first-ever COVID-19 pill may be just weeks away. A handful of other pills, inhalers, and nasal sprays also show promise.
Easy-to-take coronavirus treatments could complement vaccines. These are the most promising ones to…
Aria Bendix,Andrew Dunn
2 mins read
What's ahead for COVID-19 treatments after Pfizer says its antiviral pill works
These are Insider's biggest healthcare stories for the week ending November 5.
Leah Rosenbaum
4 mins read
Sun Pharma, Dr Reddy’s Lab, Divi’s Lab and other pharma stocks rally on regulator’s nod to make anti-COVID pill
Pharmaceutical company stocks were the top gainers in a weak market on December 29 as the segment c…
3 mins read
The FDA could authorize the first COVID-19 pill in December - here's who may be eligible
Next month, the FDA will meet to discuss Merck's antiviral pill for adults with mild to moderate CO…
Aria Bendix
1 min read
A new pill designed to treat active COVID-19 infections was just approved by the UK, the first country to do so
Early trial results found that Merck's molnupiravir, the first antiviral designed to treat COVID-19…
Mary Hanbury
1 min read
Merck requests FDA authorization for its anti-COVID-19 pill, the next step towards rolling it out
The pill "significantly reduced the risk of hospitalization or death," according to the developers …
Marianne Guenot
4 mins read
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns
A COVID-19 pill could prevent infected people from getting seriously sick. But the FDA panel expres…
Andrew Dunn,Andrea Michelson
2 mins read
ICMR experts reject inclusion of Molnupiravir in COVID-19 treatment guidelines for fourth time citing safety concerns
Responding to a question over Molnupiravir's inclusion in the treatment guidelines amid doctors …
PTI
2 mins read
Dow spikes 482 points after Merck's COVID-19 pill boosts recovery optimism
US stocks still closed the week lower on Friday, but well off the lows sparked by higher interest r…
Matthew Fox
1 min read
Pfizer soars 11% on strong results from COVID-19 pill study, while Moderna and Merck tumble
Pfizer plans to seek the Food and Drug Administration's OK this month for the pill, with doses pote…
Phil Rosen
1 min read
Moderna and BioNTech plummet more than 15% following news of Merck's COVID-19 antiviral pill
The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still strugg…
Matthew Fox
4 mins read
Merck is set to make billions off a COVID-19 pill that could change the pandemic. Here's why some countries will pay more than others.
Merck's antiviral has not yet been authorized, but the company already has plans to distribute the …
Andrew Dunn
1 min read
Merck says it'll ask regulators to authorize the first antiviral pill designed to treat COVID-19 after a trial found it halved the risk of hospitalization or death
Merck and Ridgeback on Friday morning said they'd apply for emergency FDA authorization for the dru…
Grace Dean
2 mins read
The 2 factors that will determine if Omicron is a true threat, according to Pfizer's top scientist
These are Insider's biggest healthcare stories for December 1.
Leah Rosenbaum
1 min read
Top Stories this PM: Merck requests authorization for anti-COVID pill; Facebook Oversight Board to meet with whistleblower
If authorized, the drug, called molnupiravir, would become the first oral antiviral treatment for C…
INSIDER
3 mins read
Companies are racing to develop pills to treat COVID-19
These are Insider's biggest healthcare stories for the week ending October 1.